Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle.
Theranostics
; 12(2): 796-816, 2022.
Article
in En
| MEDLINE
| ID: mdl-34976214
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ferrosoferric Oxide
/
Metal Nanoparticles
/
Drug Repositioning
Type of study:
Diagnostic_studies
Limits:
Animals
/
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Theranostics
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: